Navigation Links
GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
Date:8/19/2007

ssets 242 270

Total assets $1,328 $2,396

Liabilities and stockholders' equity

Current liabilities $515 $193

Stockholders' equity (deficit) 813 2,203

Total liabilities and stockholders' equity $1,328 $2,396

Shares Outstanding 712,835 711,168

About GeoVax Labs, Inc.

GeoVax Inc. is an Atlanta, Georgia USA biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's vaccine technology is protected by 20 issued and filed patent applications.

GeoVax's DNA and Recombinant MVA HIV/AIDS vaccines:

* Protected 22 of 23 (96%) non-human primates for over 31/2 years post-

infection with an AIDS causing virus - 5 of 6 non-vaccinates controls

died of AIDS

* Are manufactured and tested under GMP/GLP - EMEA (EU) and FDA guidelines

* Satisfactorily completed early Phase 1 human clinical trial for DNA

HIV/AIDS vaccine

* Are currently in 2 ongoing human trials started in 2006 with positive

immune responses reported in the majority of vaccine recipients as well

as good vaccine safety

* Began 2 additional human trials in June 2007 with a large Phase 2 trial

in planning for 2008

Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limite
'/>"/>

SOURCE GeoVax Labs, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related biology technology :

1. Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A
2. In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate
3. CIOs looking to hire more IT workers in second quarter
4. DNASTAR catches second wave of sequencing
5. 9 tips for making 90 seconds count in an investment pitch
6. City of Hope adds second TomoTherapy system
7. UW-Madison hybrid-vehicle team places second nationally
8. Just one nanosecond: Clocking events at the nanoscale
9. MATCs new computer security program gears up for second semester
10. Weather Central launches second satellite
11. nPoint Secures Second Round of Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... According to a new market ... Medicine (Bone and Joint) Market (By Technology - ... Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic ... Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... joint) market was valued at USD 2.6 billion ...
(Date:7/28/2014)... MD (PRWEB) July 28, 2014 ... personalized medicine, will be exhibiting data and research conducted ... International Spine Intervention Society’s (ISIS) 22nd Annual ... 3rd, at the Hyatt Regency, in Orlando, Florida. ... knowledge and clinical competence of physicians who care for ...
(Date:7/28/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... synthetic biology covers the designing and engineering of completely ... the redesigning of natural biological systems that provide improved ... form of extreme genetic engineering because it not only ...
(Date:7/28/2014)... , July 28, 2014 /PRNewswire/ -   JOLT , ... of companies to join its growing portfolio of startups. ... Toronto,s JOLT accelerator, and Cohort ... the roster. Since its launch in ... successfully raised  $7.5M of financing. Now at 23 investments, ...
Breaking Biology Technology:Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2Global Synthetic Biology Market 2014-2018 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3
... 7 /PRNewswire-FirstCall/,-- Evotec AG (Frankfurt Stock Exchange: EVT) ... I safety and tolerability study with EVT,302. The ... EVT,302 and are an encouraging basis for further ... highly selective inhibitor of MAO-B in,development for smoking ...
... 7 Romark Laboratories, L.C., a,privately-owned biotechnology ... M.A.C.P., has joined the Company as Vice ... Dr. Keeffe served as Professor of Medicine, ... Transplant Program at Stanford,University Medical Center. He ...
... Management business, NATICK, Mass., Jan. 4 ... that it has completed the sale of,the controlling ... program to former principals and shareholders of Advanced,Bionics. ... sale,coincides with the closing of the amended merger ...
Cached Biology Technology:Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 2Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 3Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 4Phase I Safety and Tolerability Study With EVT 302 Successfully Completed 5Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer 2Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 2Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program 3
(Date:7/28/2014)... that have seen an increase in so-called "nuisance flooding"--which ... storm drains and compromised infrastructure--are on the East Coast, ... nuisance flooding, caused by rising sea levels, has increased ... percent since the 1960s. , The report, Sea Level ... States, also finds Annapolis and Baltimore, Maryland, lead the ...
(Date:7/28/2014)... is no cure for Alzheimer,s disease and other forms ... closer to finding treatment. , University of Washington bioengineers ... the harmful changes of the body,s normal proteins into ... Alzheimer,s, Parkinson,s, heart disease, Type 2 diabetes and Lou ... they shift from their normal state into an abnormally ...
(Date:7/28/2014)... Ore. The findings of a new study suggest two ... may not work as well in obese women, compared to ... pills are a one-size-fits-all method, researchers say, but as the ... well the pill works for obese women. Studies have consistently ... in the body, which may in turn affect how well ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Strategies identified to improve oral contraceptive success with obese women 2
... kidney or ureteral stones can now read EAU ... Laparoscopy and Urotechnology Section of the Hellenic Urologic ... the Spanish translation is the result of a ... and the Dominican Republic Society of Urology (SDU)., ...
... This release is available in French . ... back pain after a car accident, avoiding the harmful effects ... is particularly important for people with a smaller-than-average hippocampus, as ... are the findings of a study by Dr. Pierre Rainville, ...
... scientists have developed an algorithm that could help make DNA ... to researchers of all stripes. Andrew Smith, a computational ... Sciences, developed the algorithm along with USC graduate student Timothy ... to be published in Nature Methods on February ...
Cached Biology News:EAU Patient Information now available in Spanish and Greek 2Preventing chronic pain with stress management 2Taking the gamble out of DNA sequencing 2
... INK4a-ARF locus encodes two unrelated proteins both ... arrests the cell cycle in a p53-dependent ... the rapid degradation of mdm2 proteinrequired for ... accumulation. This interaction is mediated by ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Mfr ...
... Insulin exerts its effects ... insulin receptor, a disulfide-linked ... two Alpha subunits and ... in the following configuration: ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Mfr ...
Biology Products: